Envista (NYSE:NVST) PT Lowered to $17.50

Envista (NYSE:NVST) had its price objective reduced by The Goldman Sachs Group from $20.00 to $17.50 in a report published on Friday morning, Benzinga reports. They currently have a sell rating on the stock.

NVST has been the topic of several other reports. Needham & Company LLC reiterated a hold rating on shares of Envista in a research report on Thursday, May 2nd. SVB Leerink initiated coverage on Envista in a research report on Monday, February 26th. They set an underperform rating and a $19.00 price objective for the company. JPMorgan Chase & Co. lowered their target price on Envista from $29.00 to $23.00 and set an overweight rating on the stock in a research report on Thursday, May 2nd. Morgan Stanley lowered Envista from an overweight rating to an equal weight rating and reduced their price target for the stock from $33.00 to $21.00 in a research report on Friday, April 26th. Finally, Leerink Partnrs reissued an underperform rating on shares of Envista in a report on Monday, February 26th. Three research analysts have rated the stock with a sell rating, seven have given a hold rating and two have issued a buy rating to the company’s stock. According to MarketBeat, the stock currently has an average rating of Hold and a consensus price target of $25.86.

Envista Trading Up 0.3 %

Shares of NYSE NVST opened at $19.07 on Friday. The firm’s 50-day moving average price is $20.66 and its two-hundred day moving average price is $22.50. Envista has a 52-week low of $18.09 and a 52-week high of $36.14. The company has a debt-to-equity ratio of 0.34, a current ratio of 2.27 and a quick ratio of 1.93.

Envista (NYSE:NVST) last announced its quarterly earnings results on Wednesday, May 1st. The company reported $0.26 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.31 by ($0.05). Envista had a positive return on equity of 5.84% and a negative net margin of 4.70%. The company had revenue of $623.60 million during the quarter, compared to the consensus estimate of $634.85 million. During the same period last year, the business posted $0.38 EPS. The company’s revenue for the quarter was down .6% on a year-over-year basis. On average, research analysts predict that Envista will post 1.26 earnings per share for the current fiscal year.

Hedge Funds Weigh In On Envista

Several large investors have recently made changes to their positions in the business. Headinvest LLC bought a new stake in Envista during the third quarter worth approximately $28,000. Fifth Third Bancorp grew its holdings in shares of Envista by 98.1% in the 4th quarter. Fifth Third Bancorp now owns 1,254 shares of the company’s stock worth $30,000 after acquiring an additional 621 shares during the last quarter. Itau Unibanco Holding S.A. acquired a new stake in shares of Envista during the third quarter worth $47,000. Signaturefd LLC lifted its holdings in shares of Envista by 1,297.9% during the fourth quarter. Signaturefd LLC now owns 2,614 shares of the company’s stock valued at $63,000 after purchasing an additional 2,427 shares during the last quarter. Finally, Covestor Ltd boosted its position in shares of Envista by 33.9% in the 3rd quarter. Covestor Ltd now owns 2,462 shares of the company’s stock valued at $69,000 after purchasing an additional 624 shares during the period.

About Envista

Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, markets, and sells dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment offers dental implant systems, guided surgery systems, biomaterials, and prefabricated and custom-built prosthetics to oral surgeons, prosthodontists and periodontists, and general dentist; and brackets and wires, tubes and bands, archwires, clear aligners, digital orthodontic treatments, retainers, and other orthodontic laboratory products.